Tag: Zeposia
Bristol Myers Squibb’s Zeposia angles for lucrative ulcerative colitis nod with...
Bristol Myers Squibb notched a big win with its recent approval of multiple sclerosis drug Zeposia, a Celgene pipeline pickup with blockbuster aspirations. Not content to ride its...
Bristol Myers Squibb’s Zeposia launches into crowded MS market
When Bristol Myers Squibb nabbed Celgene's long-sought FDA nod for multiple sclerosis drug Zeposia, the COVID-19 pandemic was in full swing—not the ideal time...